[In vitro bactericidal activities of new oral penem, faropenem against the various clinical isolates]

K Matsuzaki1, T Nishiyama, M Hasegawa

  • 1Chemotherapy Division, Mitsubishi-Kagaku Bio-Clinical Laboratories, Tokyo, Japan.

Insights

Faropenem (FRPM) demonstrates potent in vitro antibacterial activity against Gram-positive bacteria and comparable efficacy to new oral cephems against Gram-negative bacteria, suggesting its clinical utility for bacterial infections.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Oral beta-lactams are commonly used for bacterial infections.
  • Evaluating new antibiotics like faropenem (FRPM) is crucial for expanding treatment options.
  • Understanding the in vitro activity spectrum of FRPM is essential for its clinical application.

Purpose of the Study:

  • To compare the in vitro antibacterial activity of faropenem (FRPM) with various oral beta-lactams.
  • To determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of FRPM.
  • To assess the bactericidal activity of FRPM against clinical isolates.

Main Methods:

  • Testing FRPM and oral beta-lactams against 15 isolates each of 6 bacterial species.
  • Determining MIC and MBC values for each antibiotic and isolate.
  • Comparing the activity profiles of FRPM and reference antibiotics.

Main Results:

  • FRPM exhibited potent in vitro activity against aerobic and anaerobic Gram-positive bacteria.
  • FRPM showed comparable activity to new oral cephems against Gram-negative bacteria, with lower susceptibility in K. pneumoniae strains.
  • The MBC of FRPM was equal to or within one dilution of the MIC for tested strains, indicating bactericidal activity.

Conclusions:

  • Faropenem (FRPM) possesses excellent in vitro antibacterial and bactericidal activity against clinical isolates.
  • FRPM demonstrates promising efficacy comparable to existing oral beta-lactams.
  • FRPM is suggested to be a clinically useful agent for the chemotherapy of bacterial infections.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...